Lily Lu

Chemotherapy-Refractory Diffuse Large B-Cell Lymphoma and Indolent B-Cell Malignancies Can Be Effectively Treated With Autologous T Cells Expressing an Anti-CD19 Chimeric Antigen Receptor

James N. Kochenderfer, Mark E. Dudley, Sadik H. Kassim et al. · Journal of Clinical Oncology · 2014 · 1.6K citations · Full text

HIF-1α regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment

Cesar A. Corzo, Thomas Condamine, Lily Lu et al. · The Journal of Experimental Medicine · 2010 · 1.1K citations · Full text

Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma

Stephanie L. Goff, Mark E. Dudley, Deborah E. Citrin et al. · Journal of Clinical Oncology · 2016 · 386 citations · Full text

Pilot Trial of Adoptive Transfer of Chimeric Antigen Receptor–transduced T Cells Targeting EGFRvIII in Patients With Glioblastoma

Stephanie L. Goff, Richard A. Morgan, James C. Yang et al. · Journal of Immunotherapy · 2019 · 362 citations · Full text

Deletion Variant, Cell Therapy, Immunology +24

Germline mutations in ETV6 are associated with thrombocytopenia, red cell macrocytosis and predisposition to lymphoblastic leukemia

Leila Noetzli, Richard Lo, Alisa B. Lee‐Sherick et al. · Nature Genetics · 2015 · 322 citations · Full text

Hematological Malignancy, Medicine, Pathogenesis +8